Education
About Us
Working with TipRanks
Follow Us
Scott Shuda Insider Profile
4 Followers
Scott Shuda, Director at Iridex, holds 129.52K shares in Iridex (Ticker: IRIX), holds 400.38K shares in InfuSystem Holdings (Ticker: INFU), holds 296.39K shares in MGC Diagnostics (Ticker: MGCD). Most recently, Scott Shuda Bought ― shares of Iridex on Apr 25, 2025 for an estimated value of $25.75K.
Profitable Transactions
8 out of 10 Profitable Transactions
Average Return
+25.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 17, 2019 - Jun 17, 2020
Return:+81.40%
The most profitable trade made by Scott Shuda
Scott Shuda's Trading History
Iridex
Apr 25, 2025
Director
Informative Buy
25.75K
$168.38K
InfuSystem Holdings
Dec 06, 2024
Director
Uninformative Sell
―
$3.78M
MGC Diagnostics
Jun 22, 2010
―
Informative Buy
4.24K
$3.27M
List of latest transactions for each holding click on a transaction to see Scott Shuda's performance on stock
You May Also Like
Scott Shuda insider profile FAQ
What is the percentage of profitable transactions made by Scott Shuda?
The percentage of profitable transactions made by Scott Shuda is 80%.
What is the average return per transaction made by Scott Shuda?
The average return per transaction made by Scott Shuda is 25.80%.
What stocks does Scott Shuda hold?
Scott Shuda holds: IRIX, INFU, MGCD stocks.
What was Scott Shuda’s latest transaction?
Scott Shuda latest transaction was an Informative Buy of $25.75K.
What was Scott Shuda's most profitable transaction?
Scott Shuda’s most profitable transaction was an Informative Buy of INFU stock on June 17, 2019. The return on the trade was 81.40%.
What is Scott Shuda's role in Iridex?
Scott Shuda's role in Iridex is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.